CD274 and neoplasm: MT1 predominantly signals through Gi-cAMP suppression and ERK1/2, favouring neurovascular vasoconstriction and CGRP restraint, whereas MT2 more strongly couples to PI3K-Akt-Nrf2 and STAT pathways that reprogramme macrophages and down-regulate PD-L1 in tumours.